Abstract
Background/Purpose
The proximal jejunal vein which branches from the dorsal side of the superior mesenteric vein (SMV) usually drains the inferior pancreatoduodenal veins (IPDVs) and contacts the uncinate process of the pancreas. We focused on this vein, termed the proximal dorsal jejunal vein (PDJV), and evaluated the anatomical classification of the PDJV and surgical outcomes in patients with pancreatic ductal adenocarcinoma (PDAC) with PDJV involvement (PDJVI).
Methods
The jejunal veins that branch from the dorsal side of the SMV above the inferior border of the duodenum are defined as PDJVs. We investigated 121 patients who underwent upfront pancreaticoduodenectomy for PDAC between 2011 and 2017; PDJVs were resected in all patients. The anatomical classification of PDJV was evaluated using multidetector computed tomography. Surgical and prognostic outcomes of pancreticoduodenectomy for PDAC with PDJVI were evaluated.
Results
The PDJVs were classified into seven types depending on the position of the first and second jejunal veins relative to the superior mesenteric artery. In all patients, the morbidity and mortality rates were 15.7 and 0.8%, respectively. The rates for parameters including SMV resection, presence of pathological T3–4, R0 resection, and 3-year survival were 46.2, 92.3, 92.3, and 61.1%, respectively, when there was PDJVI (n = 13). When there was no PDJVI (n = 108), the rates were 60.2, 93.5, 86.1, and 58.3%, respectively. Overall, there were no significant differences.
Conclusions
Pancreaticoduodenectomy with PDJV resection is feasible for PDAC with PDJVI and satisfactory overall survival rates are achievable. It may be necessary to reconsider the resectability of PDAC with PDJVI.
Similar content being viewed by others
References
Neoptolemos JP, Stocken DD, Tudur Smith C, Bassi C, Ghaneh P, Owen E, Moore M, Padbury R, Doi R, Smith D, Büchler MW. Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: Composite data from the ESPAC-1 and -3(v1) trials. Br J Cancer 2009;100:246–250.
Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, Schramm H, Fahlke J, Zuelke C, Burkart C, Gutberlet K, Kettner E, Schmalenberg H, Weigang-Koehler K, Bechstein WO, Niedergethmann M, Schmidt-Wolf I, Roll L, Doerken B, Riess H. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: A randomized controlled trial. JAMA 2007;297:267–277.
Herman JM, Swartz MJ, Hsu CC, Winter J, Pawlik TM, Sugar E, Robinson R, Laheru DA, Jaffee E, Hruban RH, Campbell KA, Wolfgang CL, Asrari F, Donehower R, Hidalgo M, Diaz LA Jr, Yeo C, Cameron JL, Schulick RD, Abrams R. Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: Results of a large, prospectively collected database at the Johns Hopkins Hospital. J Clin Oncol 2008;26:3503–310.
Ueno H, Kosuge T, Matsuyama Y, Yamamoto J, Nakao A, Egawa S, Doi R, Monden M, Hatori T, Tanaka M, Shimada M, Kanemitsu K. A randomized phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer. Br J Cancer 2009;101:908–915.
Demir IE, Jager C, Schlitter AM, Konukiewitz B, Stecher L, Schorn S, Tieftrunk E, Scheufele F, Calavrezos L, Schirren R, Esposito I, Weichert W, Friess H, Ceyhan GO. et al. R0 versus R1 resection matters after pancreaticoduodenectomy, and less after distal or total pancreatectomy for pancreatic cancer. An Surg. 2017. https://doi.org/10.1097/SLA.0000000000002345
National Comprehensive Cancer Network (NCCN). Practice guidelines for pancreatic cancer. Available at: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp [accessed 24 July 2017].
Japan Pancreas Society. Classification of Pancreatic Carcinoma. Fourth English Edition. 2017
Kaneoka Y, Yamaguchi A, Isogai M. Portal or superior mesenteric vein resection for pancreatic head adenocarcinoma: prognostic value of the length of venous resection. Surgery 2009;145:417–425.
Hartel M, Niedergethmann M, Farag-Soliman M, Sturm JW, Richter A, Trede M, Post, S. Benefit of venous resection for ductal adenocarcinoma of the pancreatic head. Eur J Surg 2002;168:707–712.
Toomy P, Hernandez J, Morton C, Duce L, Farrior T, Villadolid D, Ross S, Rosemurgy A. Resection of portovenous structures to obtain microscopically negative margins during pancreaticoduodenectomy for pancreatic adenocarcinoma is worthwhile. Am Surg 2009;75:804–809.
Nagakawa Y, Hosokawa Y, Osakabe H, Sahara Y, Takishita C, Nakajima T, Hijikata Y, Kasahara K, Kasuhiko K, Saito K, Tsuchida A. Pancreaticoduodenectomy with right-oblique posterior dissection of superior extrapancreatic nerve plexus invasion. Hepatogastroenterology 2014;61(136):2371–2376
Nakamura M, Nakashima H, Tsutsumi K, Matsumoto H, Muta Y, Ueno D, Yoshida K, Hino K, Urakami A, Tanaka M. First jejunal vein oriented mesenteric excision for pancreatoduodenectomy. J Gastroenterol 2013;48(8):989–995.
Yamada Y, Mori H, Kiyosue H, Matsumoto S, Hori Y, Maeda T. CT assessment of the inferior peripancreatic veins: clinical significance. AJR Am J Roentgenol 2000;174:677–684.
Ibukuro K, Tsukiyama T, Mori K, Inoue Y. Peripancreatic veins on thin-section (3 mm) helical CT. AJR Am J Roentgenol 1996;167:1003–1008.
Kim HJ, Ko YT, Lim JW, Lee DH. Radiologic anatomy of the superior mesenteric vein and branching patterns of the first jejunal trunk: evaluation using multi-detector row CT venography. Surg Radiol Anat 2007;29:67–75.
Papavasiliou P, Arrangoiz R, Zhu F, Chun YS, Edwards K, Hoffman JP. The anatomic course of the first jejunal branch of the superior mesenteric vein in relation to the superior mesenteric artery. Int J Surg Oncol 2012; 2012:538769.
Ishikawa Y, Ban D, Matsumura S, Mitsunori Y, Ochiai T, Kudo A, Tanaka S, Tanabe M. Surgical pitfalls of jejunal vein anatomy in pancreaticoduodenectomy. J Hepatobiliary Pancreat Sci 2017;24:397–400.
Author information
Authors and Affiliations
Contributions
Hosokawa Y, Nagakawa Y, and Saito K, Yamaguchi H, Inoue K, Katsumata K, Itoi T, and Tsuchida A were responsible for conception and design of the work. Hosokawa Y, Sahara Y, Takishita C, Nakajima T, Hijikata Y, Osakabe H, and Shirota T were responsible for data collection. Hosokawa Y, Nagakawa Y, Tsuchiya T, Sofuni A, and Tsuchida A were responsible for data analysis and interpretation of the data. All the authors contributed to drafting the article or revising it critically. In addition, all the authors contributed to the final approval of the version to be published and all the authors agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflicts of interest.
Rights and permissions
About this article
Cite this article
Hosokawa, Y., Nagakawa, Y., Sahara, Y. et al. Surgical Outcomes of Pancreaticoduodenectomy for Pancreatic Cancer with Proximal Dorsal Jejunal Vein Involvement. J Gastrointest Surg 22, 1179–1185 (2018). https://doi.org/10.1007/s11605-018-3722-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-018-3722-0